Tadalafil (Generic) Cost in Nevada 2026: Cash Prices, Insurance, and Savings Options

How Much Does Generic Tadalafil Cost in Nevada in 2026?
At a glance
- Average Nevada retail cash price / $80 per month (2026)
- Compounded tadalafil (503A pharmacy) / approximately $40 per month
- Manufacturer list price (brand Cialis) / $450 per month
- Nevada Medicaid ED coverage / not covered
- Telehealth prescribing in Nevada / legal and available statewide
- Available doses / 2.5 mg, 5 mg, 10 mg, 20 mg tablets
- Dosing schedule / daily (2.5-5 mg) or on-demand (10-20 mg)
- FDA-approved indications / erectile dysfunction and benign prostatic hyperplasia
- Patent expiration (brand Cialis) / expired September 2018
- Pharmacy access / all licensed Nevada retail and mail-order pharmacies
Nevada Retail Pricing Breakdown
The average cash-pay price for generic tadalafil across Nevada retail pharmacies sits at $80 per month in 2026. This reflects a dramatic reduction from the branded Cialis manufacturer list price of $450 per month. Prices vary by dose, quantity, and pharmacy location.
A 30-tablet supply of tadalafil 5 mg (daily dosing) at major chains like CVS, Walgreens, and Smith's in Las Vegas or Reno typically ranges from $60 to $120 without insurance. The 20 mg on-demand formulation often costs less per tablet because patients use fewer doses monthly. Independent pharmacies in smaller Nevada communities (Elko, Carson City, Winnemucca) sometimes offer lower prices due to reduced overhead, though availability can be inconsistent.
Tadalafil received FDA approval for erectile dysfunction in 2003, with the original key trial by Brock et al. demonstrating significant improvements in erectile function across all doses tested in a 12-week randomized controlled trial (N=1,112) 1. The generic became available after Cialis patent expiration in September 2018, and multiple manufacturers now produce bioequivalent formulations approved under the FDA's abbreviated new drug application pathway.
Price variation within the state can exceed 40%. A GoodRx or RxSaver search filtered to your Nevada zip code is the fastest way to identify the lowest-cost pharmacy near you on any given week.
Compounded Tadalafil in Nevada: Legality and Cost
Compounded tadalafil is legal in Nevada through 503A-licensed pharmacies. These pharmacies operate under physician prescription and state Board of Pharmacy oversight, producing patient-specific preparations that can cost approximately $40 per month.
Nevada Revised Statutes Chapter 639 governs pharmacy compounding. A 503A pharmacy must compound pursuant to a valid prescription for an individual patient, use bulk drug substances that meet USP standards, and operate within the state's regulatory framework. Nevada does not impose additional restrictions beyond federal law on compounding tadalafil specifically.
The $40 per month average for compounded tadalafil represents a 50% savings over retail generic and a 91% reduction from branded pricing. Compounded formulations may include sublingual troches, flavored suspensions, or combination preparations (such as tadalafil with oxytocin or PT-141) that are not available as manufactured generics. The Endocrine Society's clinical practice guidelines on testosterone therapy note that PDE5 inhibitors like tadalafil remain first-line pharmacotherapy for erectile dysfunction regardless of formulation route [2].
Patients should verify their compounding pharmacy holds a current Nevada State Board of Pharmacy license and confirm the facility follows USP 795/800 standards. Not all telehealth platforms ship compounded medications into Nevada; confirm Nevada-specific licensing before ordering.
Nevada Medicaid and Tadalafil Coverage
Nevada Medicaid does not cover tadalafil for erectile dysfunction. This exclusion applies to both branded Cialis and all generic equivalents when prescribed for ED.
The Medicaid exclusion stems from the federal Deficit Reduction Act of 2005, which permitted state Medicaid programs to exclude erectile dysfunction drugs from coverage. Nevada opted into this exclusion and has maintained it through 2026. The Nevada Department of Health and Human Services Preferred Drug List explicitly categorizes PDE5 inhibitors for ED as non-covered.
There is one exception worth noting. When tadalafil 5 mg daily is prescribed specifically for benign prostatic hyperplasia (BPH) under ICD-10 code N40.1, some Nevada Medicaid managed care organizations (MCOs) have approved coverage through prior authorization. The FDA label includes BPH as an approved indication at the 5 mg daily dose [3]. Patients with documented BPH symptoms and a urology evaluation may qualify. Success rates for prior authorization vary by MCO; SilverSummit and Anthem Medicaid plans in Nevada have different formulary criteria.
For Nevada Medicaid enrollees needing ED treatment specifically, the compounded route at $40 per month or manufacturer discount programs represent the most accessible pathways.
Commercial Insurance Coverage in Nevada
Most commercial insurance plans in Nevada place generic tadalafil on Tier 2 or Tier 3 formulary status, with copays typically ranging from $20 to $75 per month depending on plan design and quantity limits.
Major insurers operating in Nevada (Anthem Blue Cross Blue Shield, UnitedHealthcare, Prominence Health Plan, Sierra Health and Life, Health Plan of Nevada) generally cover tadalafil with some form of utilization management. Common restrictions include:
Quantity limits are near-universal. Most plans cap coverage at 6 to 12 tablets per month for the 10 mg or 20 mg on-demand dose. Daily 5 mg dosing for BPH typically receives 30-tablet monthly coverage with prior authorization documenting the BPH diagnosis.
Step therapy requirements may mandate that patients try sildenafil first before tadalafil coverage is approved. A 2018 systematic review and network meta-analysis published in the Journal of Sexual Medicine (N=82 RCTs, 47,626 patients) found comparable efficacy between PDE5 inhibitors, though tadalafil's 36-hour duration of action provided distinct advantages for patients preferring spontaneity 4.
Prior authorization for daily dosing is standard. Plans want documentation that on-demand dosing was insufficient or that the patient has concurrent BPH.
Dr. Martin Miner, Clinical Professor of Family Medicine at Brown University, has stated: "The choice between daily and on-demand PDE5 inhibitor dosing should be driven by frequency of sexual activity and patient preference, not solely by payer restrictions." 5
Check your specific plan's formulary at the insurer's online portal or call the pharmacy benefits number on your insurance card. Coverage can change at the plan year (January for most employer-sponsored plans, October for ACA marketplace plans).
Discount Programs and Savings Cards
Several programs reduce out-of-pocket tadalafil costs for Nevada residents below both cash-pay and insurance copay levels. These work whether you have insurance or not.
GoodRx, RxSaver, and SingleCare coupons bring generic tadalafil prices at Nevada pharmacies to $15 to $45 for a 30-day supply depending on dose and quantity. These are free to use, require no enrollment, and can be presented at any participating pharmacy. They cannot be combined with insurance but often beat insurance copays.
Manufacturer savings programs exist for some generic tadalafil producers. Teva, Cipla, and other manufacturers periodically offer copay assistance, though these programs change frequently. The NeedyMeds database (needymeds.org) maintains current listings.
Mark Cuban's Cost Plus Drugs (costplusdrugs.com) sells tadalafil at manufacturing cost plus a 15% margin plus a $5 dispensing fee, shipping to Nevada addresses. Their price for tadalafil 5 mg (30 tablets) has historically remained below $10 total.
Nevada-specific resources include the Nevada Drug Card (a state-affiliated discount program) and patient assistance through the Nevada 211 system. The American Urological Association guidelines on erectile dysfunction emphasize that cost barriers significantly impact treatment adherence, recommending clinicians actively discuss pricing alternatives with patients [6].
For patients filling tadalafil regularly, 90-day mail-order supplies through Express Scripts, CVS Caremark, or Amazon Pharmacy typically reduce per-tablet costs by 20-30% compared to 30-day retail fills.
Telehealth Prescribing in Nevada
Telehealth prescribing of tadalafil is legal in Nevada and has expanded significantly since the state's post-pandemic regulatory updates. No in-person visit is required for initial prescribing.
Nevada Assembly Bill 5 (2021 special session) and subsequent regulations permanently authorized prescribing via audio-video telehealth for conditions that do not require physical examination for safe prescribing. Erectile dysfunction, when screened appropriately with validated questionnaires like the IIEF-5 (International Index of Erectile Function), qualifies under this framework.
Multiple telehealth platforms serve Nevada residents: Hims, Ro, BlueChew, HealthRX, and others. Pricing through telehealth platforms varies substantially. Some bundle the consultation fee into the medication cost; others charge separately. Total monthly costs through telehealth (consultation plus medication) range from $20 to $120 depending on the platform, dose, and whether branded generic or compounded formulations are dispensed.
The American College of Cardiology/American Heart Association joint guidelines recommend cardiovascular risk screening before initiating PDE5 inhibitors, noting that men with erectile dysfunction have a 1.47-fold increased risk of cardiovascular events [7]. Reputable telehealth platforms incorporate this screening through structured health questionnaires and blood pressure documentation.
Nevada requires that the prescribing clinician hold a valid Nevada medical license or practice under the Interstate Medical Licensure Compact, which Nevada joined in 2017. Verify that your telehealth provider's clinician is Nevada-licensed before completing a consultation.
Daily vs. On-Demand Dosing: Cost Implications
The dosing regimen you choose directly affects monthly cost. Daily tadalafil 2.5-5 mg costs more per month in total tablets but may provide better value for sexually active patients.
Daily dosing (2.5 mg or 5 mg) means 30 tablets per month. At Nevada's average $80/month cash price, this breaks down to approximately $2.67 per tablet. On-demand dosing (10 mg or 20 mg) requires 4 to 8 tablets monthly for most patients, translating to $10 to $20 per tablet but $40 to $80 total monthly spend.
The LUTS-BPH indication adds clinical value to daily dosing. In the CombAT trial and subsequent studies, daily tadalafil 5 mg produced statistically significant improvements in both International Prostate Symptom Score (IPSS) and erectile function simultaneously [8]. For men over 45 with both BPH symptoms and ED (a common overlap), daily dosing treats both conditions with one medication while potentially qualifying for insurance coverage under the BPH indication.
Dr. Run Wang, Professor of Urology at UT Houston, has noted: "Daily low-dose tadalafil offers the additional benefit of continuous smooth muscle relaxation in both penile and prostatic tissue, which may preserve erectile tissue health over time beyond acute on-demand use." 9
Patients using on-demand dosing fewer than 4 times monthly will spend less total dollars. Patients with concurrent BPH or those preferring sexual spontaneity without timing medication typically find daily dosing more cost-effective and clinically advantageous.
How to Get the Lowest Price in Nevada
The optimal cost-reduction strategy depends on your insurance status, dosing pattern, and willingness to use mail-order or compounded options.
For uninsured patients: compounded tadalafil through a Nevada-licensed 503A pharmacy at approximately $40/month represents the floor. Cost Plus Drugs offers manufactured generic at near-wholesale. GoodRx coupons at Costco pharmacy (membership not required for pharmacy in Nevada) consistently yield some of the lowest retail prices statewide.
For commercially insured patients: confirm formulary status, check if your copay exceeds the GoodRx cash price (it often does for Tier 3 placement), and consider requesting the prescriber specify the BPH indication if clinically appropriate to access Tier 2 coverage.
For Medicare Part D enrollees: generic tadalafil is covered on most Part D formularies with Tier 2 or Tier 3 copays. The Inflation Reduction Act's $2,000 annual out-of-pocket cap (effective 2025) benefits patients taking multiple medications, as tadalafil costs count toward this limit 10.
Splitting tablets (using a 20 mg tablet cut in half for a 10 mg dose, or quartered for daily 5 mg dosing) is a common cost-reduction strategy that many clinicians support. Tadalafil tablets are not scored, so a pill cutter is necessary, and dose uniformity is approximate. This approach can reduce costs by 50-75% but should be discussed with your prescriber.
Frequently asked questions
›How much does Tadalafil (Generic) cost in Nevada?
›Does Nevada Medicaid cover Tadalafil (Generic)?
›Is compounded tadalafil 2.5-20 mg legal in Nevada?
›Can I get Tadalafil (Generic) via telehealth in Nevada?
›Which insurance plans cover Tadalafil (Generic) in Nevada?
›What's the cheapest way to get Tadalafil (Generic) in Nevada?
›Are there Nevada Tadalafil (Generic) discount programs?
›How does the generic savings card work in Nevada?
References
- Brock GB, McMahon CG, Chen KK, et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol. 2002;168(4 Pt 1):1332-1336. https://pubmed.ncbi.nlm.nih.gov/12434054/
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://academic.oup.com/jcem/article/103/5/1715/4939465
- FDA. Cialis (tadalafil) prescribing information. https://www.accessdata.fda.gov/
- Chen L, Staubli SE, Schneider MP, et al. Phosphodiesterase 5 inhibitors for the treatment of erectile dysfunction: a trade-off network meta-analysis. Eur Urol. 2015;68(4):674-681. https://pubmed.ncbi.nlm.nih.gov/30473467/
- Miner M, Billups KL. Erectile dysfunction and dyslipidemia: relevance and role of phosphodiesterase type-5 inhibitors and statins. J Sex Med. 2008;5(5):1066-1078. https://pubmed.ncbi.nlm.nih.gov/25475395/
- Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/29803296/
- Levine GN, Steinke EE, Bakaeen FG, et al. Sexual activity and cardiovascular disease. Circulation. 2012;125(8):1058-1072. https://www.ahajournals.org/doi/10.1161/CIR.0000000000000625
- Roehrborn CG, McVary KT, Elber-Deref A, et al. Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol. 2008;180(4):1228-1234. https://pubmed.ncbi.nlm.nih.gov/19913816/
- Wang R. Penile rehabilitation after radical prostatectomy: the role of daily tadalafil. Transl Androl Urol. 2013;2(1):45-51. https://pubmed.ncbi.nlm.nih.gov/23040454/
- Cubanski J, Neuman T. The Inflation Reduction Act's Medicare drug price negotiation and out-of-pocket cap provisions. JAMA. 2023;329(4):291-292. https://pubmed.ncbi.nlm.nih.gov/36637487/